3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
9
Completed
8
Recruiting
6
Not yet recruiting
4
Terminated
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
58
Neoplasms
52
Colorectal Neoplasms
32
Prostatic Neoplasms
29
Lung Neoplasms
21
Stomach Neoplasms
17
Carcinoma, Non-Small-Cell Lung
16
Carcinoma, Hepatocellular
16
Uterine Cervical Neoplasms
13
Anxiety Disorders
13
Colonic Neoplasms
11
Brain Neoplasms
11
Pancreatic Neoplasms
10
Lymphoma, Follicular
9
Leukemia, Myeloid, Acute
8
Head and Neck Neoplasms
8
Barrett Esophagus
8
Urinary Bladder Neoplasms
7
Rectal Neoplasms
7
Esophageal Squamous Cell Carcinoma
7
Esophageal Neoplasms
7
Disease
7
Diabetes Mellitus
7
Cholangiocarcinoma
7
Sarcoma
6
Recurrence
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Pain
6
Ovarian Neoplasms
6
Motor Activity
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
OTHER
×
Chemotherapy-Related Cognitive Impairment
×
Clear all
NCT06950190
2025-08-12
(ECCPC)
Ellis Medicine
Phase 3
Enrolling by invitation
100 enrolled